Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bruker Daltonics is a leading division of Bruker Corporation that specializes in the development and manufacturing of advanced mass spectrometry instruments and analytical solutions. The company is a pioneer in MALDI-TOF technology, notably through its MALDI Biotyper platform, which has revolutionized clinical microbiology by providing rapid and accurate identification of microorganisms. Their portfolio also includes high-performance liquid chromatography-mass spectrometry (LC-MS) systems, such as the timsTOF series, which are widely used in proteomics, metabolomics, and lipidomics research. Bruker Daltonics provides essential tools for drug discovery, development, and clinical diagnostics, serving a global customer base in the pharmaceutical, biotechnology, and academic sectors. Their innovative technologies enable researchers to gain deeper insights into complex biological systems and accelerate the path to personalized medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bruker Daltonics.